Management of Pulmonary Edema
Immediate Respiratory Support (First Priority)
Apply non-invasive positive pressure ventilation (CPAP or BiPAP) immediately as the primary intervention before considering intubation—this is the single most important initial intervention that reduces both mortality (RR 0.80) and need for intubation (RR 0.60). 1, 2
- Start CPAP with initial PEEP of 5-7.5 cmH₂O, titrate up to 10 cmH₂O based on clinical response, with FiO₂ at 0.40 2
- Both CPAP and BiPAP are equally effective and work by improving oxygenation, decreasing left ventricular afterload, and reducing respiratory muscle work 1, 2
- Apply in the pre-hospital setting when possible, as this further reduces intubation need (RR 0.31) 1, 2
- Consider PS-PEEP over CPAP specifically in patients with previous COPD or signs of fatigue with acidosis and hypercapnia 1
Reserve intubation only for: 1, 3
- Persistent hypoxemia despite CPAP/BiPAP
- Hypercapnia with respiratory acidosis
- Deteriorating mental status
- Hemodynamic instability
Oxygen Therapy
- Administer supplemental oxygen **only if SpO₂ <90%** to maintain saturation >90% 1, 2, 3
- Avoid routine oxygen in non-hypoxemic patients as it causes vasoconstriction and reduces cardiac output 1, 3
Pharmacological Management: Blood Pressure-Guided Algorithm
For Systolic BP ≥100 mmHg (Most Common Presentation)
High-dose IV nitrates are first-line therapy, combined with low-dose furosemide—this combination is superior to high-dose diuretics alone and reduces mortality. 2, 3
Nitroglycerin Protocol: 1, 2, 3
- Start with sublingual nitroglycerin 0.4-0.6 mg, repeat every 5-10 minutes up to four times
- Immediately transition to IV nitroglycerin if systolic BP remains ≥95-100 mmHg
- Initial IV dose: 20 mcg/min, increase up to 200 mcg/min according to hemodynamic tolerance (alternative starting dose: 0.3-0.5 μg/kg/min)
- Check BP every 3-5 minutes during titration
- Target: 10 mmHg reduction in mean BP or systolic BP of 90-100 mmHg
- Reduce dose if systolic BP drops below 90-100 mmHg
Furosemide Protocol (Never as Monotherapy): 3, 4
- Initial dose: 40 mg IV bolus over 1-2 minutes 4
- If inadequate response after 1 hour, increase to 80 mg IV 4
- For patients on chronic oral diuretics, use dose at least equivalent to their oral dose 3
- Critical caveat: Furosemide transiently worsens hemodynamics during first 1-2 hours (increases systemic vascular resistance, increases left ventricular filling pressures, decreases ejection fraction) 3
- Sodium nitroprusside starting at 0.1 μg/kg/min for patients not responsive to nitrates, particularly effective for severe mitral/aortic regurgitation or marked systemic hypertension
- Administer 2-5 mg IV for patients with severe restlessness and dyspnea
- Contraindications: chronic pulmonary insufficiency, respiratory or metabolic acidosis, respiratory depression
For Systolic BP 70-100 mmHg (Hypoperfusion Without Shock)
For Systolic BP <70 mmHg (Cardiogenic Shock)
- Norepinephrine 30 mcg/min IV 2
- Dopamine 5-15 mcg/kg per minute IV 2
- Consider intra-aortic balloon counterpulsation 2
Management of Specific Underlying Causes
Acute Coronary Syndrome
- Perform urgent ECG to identify ST-elevation or new left bundle branch block 2, 3
- Urgent myocardial reperfusion therapy (cardiac catheterization or thrombolytic therapy) takes priority 1, 2, 3
Hypertensive Emergency
- Aim for initial rapid reduction of systolic or diastolic BP of 30 mmHg during first few hours 1
- Use IV vasodilators (nitroglycerin or nitroprusside) with loop diuretics 1
Mechanical Complications
- Perform urgent echocardiography to estimate LV/RV function and exclude ventricular septal rupture, papillary muscle rupture, or free wall rupture 2
Advanced Interventions for Refractory Cases
Intra-Aortic Balloon Counterpulsation (IABP)
- Consider for severe refractory pulmonary edema not responding to standard therapy, particularly if urgent cardiac catheterization is needed 1, 2
- Contraindications: significant aortic regurgitation or aortic dissection 1
Pulmonary Artery Catheter Monitoring
- Consider if: 1, 2, 3
- Clinical course is deteriorating
- Recovery does not progress as expected
- High-dose vasodilators or inotropes required
- Diagnostic uncertainty remains
Renal Replacement Therapy
- In severe renal dysfunction with refractory fluid retention, continuous veno-venous hemofiltration (CVVH) may be necessary 1
Critical Pitfalls to Avoid
Never use these approaches—they increase mortality and morbidity: 2, 3
- Low-dose nitrates: Limited efficacy and potential failure to prevent intubation 2, 3
- High-dose diuretics in monotherapy: Worsens hemodynamics and increases mortality 2, 3
- Beta-blockers or calcium channel blockers acutely: Class III recommendation (harm) in patients with frank cardiac failure evidenced by pulmonary congestion 1, 2
- Aggressive simultaneous use of multiple hypotensive agents: Initiates cycle of hypoperfusion-ischemia leading to iatrogenic cardiogenic shock 1, 2
- Aggressive diuresis: Associated with worsening renal function and increased long-term mortality 1, 3
Monitoring Parameters
- Monitor vital signs including systolic BP, heart rhythm, heart rate, oxygen saturation, and urine output regularly until stabilization 1
- Assess for electrolyte imbalance as side effect of diuretic therapy 1
- Nitrate tolerance: Efficacy is limited to 16-24 hours with continuous high-dose IV infusion; monitor for tolerance which develops rapidly 1, 3